Sales and Marketing

News

Alzheimer's drug Leqembi launched in first EU markets

Germany and Austria are the first countries in the EU to see the launch of Leqembi, Eisai and Biogen's much-delayed treatment for Alzheimer's.

News

Iterum brings first oral penem antibiotic to US market

Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.

Digital

How consumer data is redefining HCP engagement

The way brands engage healthcare providers (HCPs) is undergoing a seismic shift in today’s digital-first healthcare ecosystem. The sales rep model is fading.

News

CSL will slash headcount and hive off vaccine business

Facing declines in flu vaccination rates in the US, CSL will spin out its vaccine unit as part of a wider restructuring that will claim 3,000 jobs.

News

Novo Nordisk cuts GLP-1 prices for cash buyers

Novo Nordisk has said it will offer diabetes therapy Ozempic at $499 per month for cash-paying customers in the US.

News

EVERSANA unveils industry's 'first AI marketing agency'

EVERSANA has ramped up the application of artificial intelligence to pharma marketing with the launch of The AI Agency.

Alzheimer's drug Leqembi launched in first EU markets

Iterum brings first oral penem antibiotic to US market

How consumer data is redefining HCP engagement

CSL will slash headcount and hive off vaccine business

Novo Nordisk cuts GLP-1 prices for cash buyers

EVERSANA unveils industry's 'first AI marketing agency'

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

Sales and Marketing

Editor's Picks